NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/07/2026
Back to search
Official data from USPTO
LIZTOX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
05/08/2026
Trademark type
Word
Nice classes
5
Filing date
12/23/2019
Registration date
09/22/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/22/2020
Last transaction
05/08/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
KR
Examiner
VAGHANI, MAYUR C
Law office
O30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Huons Bio Pharma Co., Ltd.
Huons Global Co., Ltd.
Representatives
Jae Youn Kim Novick, Kim & Lee, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Food for babies; lactose for pharmaceutical purposes; nutritional supplements; pharmaceutical agents affecting sensory organs; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; pharmaceutical products for the treatment of viral diseases; pharmaceuticals for the treatment of erectile dysfunction; pharmaceuticals being medicines for alleviating constipation; pharmaceutical products for the treatment of bone diseases; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; pharmaceutical preparationsophthalmic preparations; pharmaceutical preparations for treating allergies; pharmaceutical products for the treatment of cancer; pharmaceutical agents for epidermis; pharmaceuticals being medicines for the treatment of gastrointestinal diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating asthma; pharmaceuticals being medicines for dental purposes; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations for respiratory organs; pharmaceuticals being antihistamines; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment of diseases of the genitourinary system; pharmaceutical preparations for the prevention of diseases of the genitourinary system; pharmaceutical preparations for treating obesity; pharmaceuticals being cardiotonics; cardiovascular pharmaceuticals; pharmaceutical preparationsantipyretic preparations; pharmaceutical preparationsanalgesic preparations; pharmaceutical preparationsanti-inflammatory preparations; pharmaceuticals being anaesthetics; pharmaceutical products for the treatment of infectious diseases; pharmaceuticals being chemotherapeutics; pharmaceuticals being psychotropics; pharmaceutical products for skin care for animals; pharmaceutical preparations for the treatment of worms in pets; Veterinary preparationsanti-infective products for veterinary use; Veterinary preparationsveterinary vaccines; veterinary preparations for treatment of intestinal bacteria; food supplements; dietary supplements; nutraceuticals for use as dietary supplements; nutraceutical preparations for therapeutic or medical purposes for the treatment of obesity; nutraceutical preparations for therapeutic or medical purposes for the treatment of intestinal disorders; nutraceutical preparations for therapeutic or medical purposes for the treatment of allergies; nutraceutical preparations for therapeutic or medical purposes for the treatment of gastrointestinal diseases; medicated plasters; deodorantsother than for human beings or for animalsair deodorantsdeodorants for clothingdeodorants for textileshousehold deodorantsroom deodorants; bacterial preparations for medical and veterinary use; medicine casesportablefilledwith pharmaceutical preparations for the treatment of viral diseases; medicine casesportablefilledwith pharmaceutical preparations for the treatment of intestinal disorders; medicine casesportablefilledwith pharmaceutical preparations for the treatment of inflammatory diseases; sanitary pads; adhesives for dentures; diapers for incontinence; babies' diapers; diapers for pets; fly glue; mothproofing paper
Publications
History of USPTO decisions and trademark events.
25 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/22/2025
CHLD
CHANGE OF OWNER RECEIVED FROM IB
08/28/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/30/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/08/2021
FIMP
FINAL DISPOSITION PROCESSED
01/08/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/22/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
09/22/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/07/2020
PUBO
PUBLISHED FOR OPPOSITION
07/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/17/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/02/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/14/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/14/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/14/2020
RFNT
REFUSAL PROCESSED BY IB
05/01/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/09/2020
RFRR
REFUSAL PROCESSED BY MPU
04/09/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/25/2020
CNRT
NON-FINAL ACTION WRITTEN
03/24/2020
DOCK
ASSIGNED TO EXAMINER
03/19/2020
MAFR
APPLICATION FILING RECEIPT MAILED
02/15/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/11/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
02/10/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/06/2020
Continuous trademark protection
Get notified about every new filing that threatens LIZTOX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.